Impact of adalimumab on clinical outcomes, healthcare resource utilization, and sick leave in patients with ankylosing spondylitis: an observational study from five Central and Eastern European countries

BACKGROUND: Patients with ankylosing spondylitis (AS) are substantial users of healthcare resources due to chronic and potentially disabling disease. This study assessed the impact of adalimumab on clinical outcomes, healthcare resource utilization, and sick leave in patients with AS in five Central...

Descripción completa

Detalles Bibliográficos
Autores principales: Opris-Belinski, Daniela, Erdes, Shandor F, Grazio, Simeon, Šenolt, Ladislav, Hojnik, Maja, Nagy, Orsolya, Marina, Diana, Szántó, Sándor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251385/
https://www.ncbi.nlm.nih.gov/pubmed/30483351
http://dx.doi.org/10.7573/dic.212556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251385/
https://www.ncbi.nlm.nih.gov/pubmed/30483351
http://dx.doi.org/10.7573/dic.212556

Ejemplares similares